evofosfamide,
TH 302,
TH-302,
TH302 cpd,
TH-302,
evofosfamide,
918633-87-1,
TH 302,
TH302,
UNII-8A9RZ3HN8W,
n,n'-bis(2-bromoethyl)phosphorodiamidic acid (1-methyl-2-nitro-1h-imidazol-5-yl)methyl ester,
Evofosfamide(TH 302),
8A9RZ3HN8W,
compound 3b,
TH-302; Evofosfamide;HAP-302,
2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine,
Phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester,
Evofosfamide [USAN:INN],
Evofosfamide(TH-302),
Evofosfamide (TH-302),
C9H16Br2N5O4P,
CHEMBL260046,
Evofosfamide (JAN/USAN/INN),
GTPL8695,
SCHEMBL2357174,
SCHEMBL15691894,
KS-00001CSJ,
DTXSID60238721,
HAP-302,
BCP06074,
EX-A1740,
s2757,
ZINC29053729,
AKOS026673946,
ACN-037524,
CS-0616,
RL05790,
SB17116,
4CA-1246,
AC-29025,
AK198685,
HY-10535,
FT-0696771,
X5809,
J3.504.735B,
D10704,
W-5941,
J-523214,
918633-87-1 , C9H16Br2N5O4P , TH302 , TH 302,
(1-Methyl-2-nitro-1H-imidazol-5-yl)methyl N,N'-bis(2-bromoethyl)phosphorodiamidate,
TH302 cpd,
D0H1EA,
cc-588,
CID11984561,
A3872,
C552526,
(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl)diamidophosphate,
2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitro-imidazol-4-yl)methoxy]phosphoryl]ethanamine,